BOSTON,
Sept. 27, 2024 /PRNewswire/ -- With the Drug Supply Chain Security Act (DSCSA) stabilization period ending on
November 27, 2024, the TraceLink customer and trading partner community of healthcare and life sciences companies continues to demonstrate market leadership in demonstrating compliance readiness. TraceLink's 290,000-strong B2N Integrate-Once™network has been instrumental in supporting customers to rapidly integrate with key supply chain partners, exchange required compliance information, automate compliance processes, and mitigate operational risks.
In the past 90 days, TraceLink customers have exchanged over 6 million DSCSA Electronic Product Code Information Services (EPCIS) transactions, reflecting a significant surge in compliance activities. Impressively, 43% of all EPCIS transactions over the past 12 months occurred during this period, underscoring the momentum of compliance initiatives as companies race to meet the deadline. Additionally, 2,590 new links with supply chain partners were established, enabling over 2,010 companies and 540 customers to seamlessly exchange critical EPCIS data.
